Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 8 studies | 26% ± 11% | |
fibroblast | 7 studies | 26% ± 6% | |
pericyte | 5 studies | 30% ± 12% | |
endothelial cell | 4 studies | 24% ± 6% | |
basal cell | 3 studies | 30% ± 5% | |
vein endothelial cell | 3 studies | 27% ± 14% | |
astrocyte | 3 studies | 19% ± 2% |
Insufficient scRNA-seq data for expression of ACKR3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 97% | 1816.11 | 319 / 328 | 90% | 51.66 | 160 / 178 |
breast | 99% | 6587.70 | 455 / 459 | 87% | 52.18 | 972 / 1118 |
bladder | 100% | 4977.52 | 21 / 21 | 86% | 82.29 | 432 / 504 |
thymus | 100% | 5421.57 | 651 / 653 | 80% | 47.95 | 483 / 605 |
esophagus | 94% | 3937.67 | 1353 / 1445 | 81% | 118.09 | 148 / 183 |
intestine | 98% | 3192.75 | 944 / 966 | 76% | 31.43 | 398 / 527 |
lung | 93% | 2221.98 | 537 / 578 | 80% | 152.80 | 920 / 1155 |
uterus | 89% | 1720.16 | 151 / 170 | 81% | 109.51 | 374 / 459 |
stomach | 63% | 1879.18 | 227 / 359 | 78% | 29.94 | 224 / 286 |
ovary | 54% | 1047.33 | 97 / 180 | 74% | 42.80 | 318 / 430 |
brain | 25% | 315.66 | 661 / 2642 | 98% | 81.11 | 691 / 705 |
skin | 85% | 2682.23 | 1531 / 1809 | 31% | 11.96 | 144 / 472 |
prostate | 81% | 1779.80 | 198 / 245 | 32% | 9.68 | 161 / 502 |
blood vessel | 100% | 7828.25 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 5314.26 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 295.62 | 1 / 1 |
adipose | 100% | 9164.49 | 1203 / 1204 | 0% | 0 | 0 / 0 |
kidney | 21% | 354.36 | 19 / 89 | 77% | 96.95 | 690 / 901 |
heart | 97% | 3357.21 | 833 / 861 | 0% | 0 | 0 / 0 |
liver | 40% | 1233.85 | 91 / 226 | 51% | 23.90 | 207 / 406 |
tonsil | 0% | 0 | 0 / 0 | 89% | 250.07 | 40 / 45 |
muscle | 80% | 1628.51 | 645 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 8% | 136.11 | 20 / 258 | 50% | 42.49 | 115 / 230 |
lymph node | 0% | 0 | 0 / 0 | 24% | 5.70 | 7 / 29 |
eye | 0% | 0 | 0 / 0 | 20% | 5.77 | 16 / 80 |
peripheral blood | 16% | 431.37 | 147 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0031623 | Biological process | receptor internalization |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_1905322 | Biological process | positive regulation of mesenchymal stem cell migration |
GO_0001570 | Biological process | vasculogenesis |
GO_0007155 | Biological process | cell adhesion |
GO_0006955 | Biological process | immune response |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_1902230 | Biological process | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0021557 | Biological process | oculomotor nerve development |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0060326 | Biological process | cell chemotaxis |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0055037 | Cellular component | recycling endosome |
GO_0005769 | Cellular component | early endosome |
GO_0009986 | Cellular component | cell surface |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0005768 | Cellular component | endosome |
GO_0015026 | Molecular function | coreceptor activity |
GO_0016494 | Molecular function | C-X-C chemokine receptor activity |
GO_0005044 | Molecular function | scavenger receptor activity |
GO_0016493 | Molecular function | C-C chemokine receptor activity |
GO_0019958 | Molecular function | C-X-C chemokine binding |
GO_0019957 | Molecular function | C-C chemokine binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ACKR3 |
Protein name | Atypical chemokine receptor 3 Atypical chemokine receptor 3 (C-X-C chemokine receptor type 7) (CXC-R7) (CXCR-7) (Chemokine orphan receptor 1) (G-protein coupled receptor 159) (G-protein coupled receptor RDC1 homolog) (RDC-1) |
Synonyms | CMKOR1 GPR159 CXCR7 RDC1 |
Description | FUNCTION: Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Acts as a receptor for chemokines CXCL11 and CXCL12/SDF1 . Chemokine binding does not activate G-protein-mediated signal transduction but instead induces beta-arrestin recruitment, leading to ligand internalization and activation of MAPK signaling pathway . Required for regulation of CXCR4 protein levels in migrating interneurons, thereby adapting their chemokine responsiveness . In glioma cells, transduces signals via MEK/ERK pathway, mediating resistance to apoptosis. Promotes cell growth and survival . Not involved in cell migration, adhesion or proliferation of normal hematopoietic progenitors but activated by CXCL11 in malignant hemapoietic cells, leading to phosphorylation of ERK1/2 (MAPK3/MAPK1) and enhanced cell adhesion and migration . Plays a regulatory role in CXCR4-mediated activation of cell surface integrins by CXCL12 . Required for heart valve development . Regulates axon guidance in the oculomotor system through the regulation of CXCL12 levels . .; FUNCTION: (Microbial infection) Acts as a coreceptor with CXCR4 for a restricted number of HIV isolates. . |
Accessions | P25106 A0A140T9K6 ENST00000272928.4 ENST00000447924.1 |